Becton, Dickinson and Co. | Les Charges D'Exploitation



Operating Expenses Changement Date
Abbott USD 9.06B 298M 2024-12
Agilent USD 1.31B 12M 2025-01
Align Technology USD 851.07M 35.5M 2024-12
Avanos Medical USD 598.1M 439.7M 2024-12
Baxter International USD 3.19B 644M 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Bio-Rad Laboratories USD 609.1M 23.84M 2024-12
Boston Scientific USD 3.89B 410M 2024-12
Cooper Companies USD 782.7M 37.3M 2025-01
Danaher USD 5.11B 273M 2024-12
Dentsply International USD 1.41B 1000K 2024-12
Dexcom USD 924.6M 82.4M 2024-12
Edwards Lifesciences USD 1.07B 69.4M 2024-12
Exact Sciences USD 1.59B 841.72M 2024-12
Globus Medical USD 597.02M 19.41M 2024-12
Hologic USD 792M 34M 2024-12
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
Intuitive Surgical USD 1.68B 882M 2024-12
J&J USD 18.63B 500M 2024-12
Masimo USD 959.8M 485.3M 2024-12
Medtronic USD 6.65B 162M 2025-01
Patterson Companies USD 1.53B 109.77M 2025-01
Solventum Corp 1.94B 131M 2024-12
Stryker USD 5.86B 1.45B 2024-12
Tandem Diabetes Care USD 283.23M 13.17M 2024-12
Teleflex USD 905.79M 290.73M 2024-12
Terumo JPY 217.77B 10.36B 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12



Becton, Dickinson and Co. Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.